Glaxosmithkline Pharmaceuticals is currently trading at Rs. 1232.00, up by 2.15 points or 0.17% from its previous closing of Rs. 1229.85 on the BSE.
The scrip opened at Rs. 1229.85 and has touched a high and low of Rs. 1238.90 and Rs. 1225.20 respectively.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1812.00 on 11-Sep-2018 and a 52 week low of Rs. 1,225.20 on 24-Jun-2019.
Last one week high and low of the scrip stood at Rs. 1259.50 and Rs. 1225.20 respectively. The current market cap of the company is Rs. 20987.71 crore.
The promoters holding in the company stood at 75.00%, while Institutions and Non-Institutions held 12.53% and 12.47% respectively.
GlaxoSmithKline Pharmaceuticals is optimising its product portfolio with focus on key brands to accelerate growth in India. The company is also looking to launch some new products in the country over the next 15 months as it adopts a more structured approach to engage trade channel partners, with a dedicated team to engage stockists and retailers across India.
GlaxoSmithKline Pharmaceuticals (GSK Rx India) is one of the oldest pharmaceuticals company. The GSK India product portfolio includes prescription medicines and vaccines.